Abstract
We conducted pharmacokinetic haemodynamic studies in 10 patients with congestive cardiac failure to determine both the time to steady state concentration after commencement of a standard infusion rate of 21 micrograms/min i.v. GTN and the haemodynamic response once steady state plasma concentration ws achieved. Nitroglycerin was detected in plasma 2 min after commencement of the infusion, the concentration rose to a peak of approximately 4 ng/ml at 30 min and was maintained throughout the balance of the infusion period. During GTN infusion heart rate, systolic blood pressure and cardiac index were unchanged; there was significant declines (P less than 0.01) in pulmonary systolic pressure (SPA) (52 to 42 mm Hg), pulmonary capillary wedge pressure (PCWP) (26 to 20 mm Hg), and right atrial pressure (RAP) (12 to 8 mm Hg). These pressure changes were first evident within 5 min, approached maximum by 10 min and were maintained throughout the remainder of the infusion period. A one compartment model fitted to haemodynamic and GTN data revealed time constants (+/- approximate standard error) for SPA, PCWP, RAP and GTN of 8.2 (3.4), 9.7 (3.0), 8.1 (3.8) and 8.1 (1.9 respectively. Clearance for GTN was 6.2 +/- 2.7 (s.d.) 1 min. These data demonstrate steady state concentration of GTN is approached asymptotically with a time constant of 8.1 min during i.v. infusion of 21 micrograms/min. The time constants for haemodynamic measurement most sensitive to GTN's effect, i.e. SPA, PCW and RAP were remarkably similar to the time constant found for GTN concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armstrong P. W., Armstrong J. A., Marks G. S. Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation. 1980 Jul;62(1):160–166. doi: 10.1161/01.cir.62.1.160. [DOI] [PubMed] [Google Scholar]
- Armstrong P. W., Moffat J. A., Marks G. S. Arterial-venous nitroglycerin gradient during intravenous infusion in man. Circulation. 1982 Dec;66(6):1273–1276. doi: 10.1161/01.cir.66.6.1273. [DOI] [PubMed] [Google Scholar]
- Cohn J. N., Levine T. B., Francis G. S., Goldsmith S. Neurohumoral control mechanisms in congestive heart failure. Am Heart J. 1981 Sep;102(3 Pt 2):509–514. doi: 10.1016/0002-8703(81)90739-0. [DOI] [PubMed] [Google Scholar]
- Cottrell J. E., Turndorf H. Intravenous nitroglycerin. Am Heart J. 1978 Oct;96(4):550–553. doi: 10.1016/0002-8703(78)90170-9. [DOI] [PubMed] [Google Scholar]
- Forrester J. S., Ganz W., Diamond G., McHugh T., Chonette D. W., Swan H. J. Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J. 1972 Mar;83(3):306–311. doi: 10.1016/0002-8703(72)90429-2. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Kock-Weser J. Drug therapy. Clinical Pharmacokinetics (first of two parts). N Engl J Med. 1975 Oct 2;293(14):702–705. doi: 10.1056/NEJM197510022931406. [DOI] [PubMed] [Google Scholar]
- Magrini F., Niarchos A. P. Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema. Am J Cardiol. 1980 Apr;45(4):841–847. doi: 10.1016/0002-9149(80)90130-7. [DOI] [PubMed] [Google Scholar]
- McNiff E. F., Yacobi A., Young-Chang F. M., Golden L. H., Goldfarb A., Fung H. L. Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. J Pharm Sci. 1981 Sep;70(9):1054–1058. doi: 10.1002/jps.2600700923. [DOI] [PubMed] [Google Scholar]
- Wei J. Y., Reid P. R. Quantitative determination of trinitroglycerin in human plasma. Circulation. 1979 Mar;59(3):588–592. doi: 10.1161/01.cir.59.3.588. [DOI] [PubMed] [Google Scholar]